ABAlexis Brinkemper

Alexis Brinkemper

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexis Brinkemper has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Thomas Armin Schildhauer

    Department of General and Trauma Surgery, BG University Hospital Bergmannsheil, Bochum, Germany

    6 shared publications
  • Mirko Aach

    Department of Spinal Cord Injuries, BG University Hospital Bergmannsheil Bochum, Bochum, Germany

    5 shared publications
  • Christiane Kruppa

    Department of General and Trauma Surgery, BG University Hospital Bergmannsheil, Ruhr-University Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany

    4 shared publications
  • Dennis Grasmücke

    Department of Spinal Cord Injuries, BG University Hospital Bergmannsheil Bochum, Bochum, Germany

    4 shared publications
  • Thomas A. Schildhauer

    Department of General and Trauma Surgery, BG University Hospital Bergmannsheil, Ruhr-University Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany

    4 shared publications
  • Charlotte Cibura

    Department of General and Trauma Surgery, BG University Hospital Bergmannsheil, Ruhr-University Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany

    3 shared publications

Latest Publications

  • Open Access

    Testing neuromuscular feedback therapy in patients with chronic spinal cord injury with residual motor function in the lower extremities compared to ‘conventional’ therapy: protocol for a multicentre randomised controlled trial

    by Mirko Aach, Alexis Brinkemper, Dennis Grasmücke, Angelika Zhivotovskaya, Matthias Königshausen, Thomas A Schildhauer, Christine Uphues, Michael Schäkermann, Marvin Pogoreuz, Anna Mai, et al.

    Study design: Multicentre randomised controlled trial. Setting: Eight spinal cord injury (SCI) centres and 15 rehabilitation centres in Germany. Objectives: To demonstrate the superiority of neuromuscular feedback therapy using an exoskeleton compared to conventional therapy in terms of improving walking ability in patients with chronic SCI. Methods: A total of 180 patients with chronic complete or incomplete SCI and residual motor function in the lower extremities are to be included. Baseline examination will be carried out at the recruiting SCI centres, followed by 1:1 randomisation at the rehabilitation centre allocating patients to the control group (conventional therapy) or the intervention group (Hybrid Assistive Limb therapy). Both interventions take place to the same extent (5×/week, 60 min) over a period of 12 weeks at the rehabilitation centres. After the 12-week intervention phase, the primary (therapy response defined as relevant improvement in at least one of the following: 6 min walk test, 10 m walk test and Walking Index for Spinal Cord Injury II score) and secondary endpoints (quality of life, pain, bladder and bowel function) are recorded by blinded observers at the SCI centres or via patient app. The effects of the intervention will be evaluated in the middle and at the end of the 6-month follow-up period. Ethics and dissemination: The study is approved by the ethics committee of the Medical Association of Westphalia-Lippe (register no. 2025–2014 f-S). The participants were informed about the aims and procedures of the study and gave their written consent. This protocol follows the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement. The study results will be published in accordance with the Consolidated Standards of Reporting Trials (CONSORT), regardless of whether the results are positive or negative. The datasets belong to the Joint Federal Committee of Germany and are available there on request. Trial registration number: DRKS 00035487.

  • Open Access

    Arthrodesis for post-traumatic ankle osteoarthritis leads to a reduced function of the affected limb with changes in gait and pedobarography: a retrospective cross-sectional study

    by Alexis Brinkemper, Thomas Rosteius, Charlotte Cibura, Lukas Karla, Thomas A. Schildhauer, Christiane Kruppa

    Background: Ankle arthrodesis is an established procedure for end-stage ankle osteoarthritis. Besides the known limited functionality, gait and foot arch changes are accompanying pathologies, which are little investigated. The aim of the present study was to determine the influence of ankle arthrodesis on gait, pedobaropraphy and functional outcome. Methods: Thirtyfive patients with unilateral ankle joint fusion after post-traumatic osteoarthritis and a mean follow-up of 60.8 months (SD 18.5, range 32–92) were included. Primary outcome were a 3-D gait analysis including pedobarography. American Orthopaedic Foot and Ankle Society (AOFAS) Score, douleur neuropathique (DN4), EQ-5D-3 L, numeric pain rating scale (NRS), Olerud-Molander Ankle Score (OMAS), painDETECT, short form 36 (SF-36), short musculoskeletal function assessment—German version (SMFA-D) and a clinical examination were secondary outcomes. Results: The AOFAS scores showed predominantly fair or poor results (Rearfoot: 48.6% fair, 34.3% poor; Midfoot 42.9% fair, 25.7% poor), while the SMFA tended to reflect mild dysfunction (bother index 31.7, functional index 27.5). Pain-related questionnaires showed a low incidence of pain (DN4 4.1, NRS 2.2, painDETECT 11.6). Kinematic changes were only marginally observed, while the spatio-temporal parameters showed relevant asymmetries between the fused and healthy side. The pedobarography revealed, in addition to other differences, a reduced maximum contact area on the arthrodesis side compared to the healthy side. Conclusions: Arthrodesis of the ankle joint results in significant limitation of daily activities with reduced function of the affected limb. The impact of ankle arthrodesis go well beyond the loss of extension and flexion, with changes in spatial and temporal movement, weight bearing profile and contact surface. However, results of pain questionnaires show a good result with regard to the main goal of the arthrodesis, the elimination of pain. Trial registration: DRKS, DRKS00033495. Registered 14 March 2024, https://www.drks.de/DRKS00033495 .

  • Open Access

    Complications after open fractures in children and adolescents - a single-center retrospective observational study

    by Alexis Brinkemper, Vanessa Marx, Thomas A. Schildhauer, Christiane Kruppa

    Purpose: Purpose of the study was to report the antibiotic treatment and complications after open fractures in children and adolescents at a level one trauma center. Methods: We retrospectively report data of 72 children and adolescents with 74 open fractures. The open fractures were evaluated according to severity, etiology, localization, concomitant injuries, therapeutic treatment, concomitant antibiotic treatment, complications and outcome. Results: We found a significant relationship between the occurrence of complications and the severity of the open fractures, the treatment method, the mechanism of injury and for the localization. A correlation between the occurrence of complications and the antibiotic treatment could not be shown. Conclusions: As the degree of injury increases, so does the likelihood of complications. There is also a correlation to treatment with external fixation, non-primary wound closure, traffic accidents and when the lower leg or foot is affected. However, the cause-and-effect relationship should always be considered.


  • Open Access

    Mid-term biomechanical gait analysis of osteosynthesis in bony Lisfranc injuries

    by Raimund H. Lülsdorff, Charlotte Cibura, Tim Ramczykowski, Alexis Brinkemper, Thomas A. Schildhauer, Valentin Rausch

  • Open Access

    Ilizarov fixator as salvage procedure after frustrating arthrodesis using intramedullary nailing - is there a chance of consolidation?

    by Alexis Brinkemper, Raimund H. Lülsdorff, Sebastian Lotzien, Christiane Kruppa, Thomas A. Schildhauer, Charlotte Cibura

    Introduction: Arthrodesis of the tibiotalar and subtalar joints is a salvage procedure that has been used successfully for years. Treatment options include internal procedures and external procedures. Retrograde intramedullary nailing is considered a safe procedure with a high degree of stability and comfort. Nevertheless, there are cases in which this internal arthrodesis fails and another procedure must be considered. Ilizarov fixator treatment could be a solution for those patients in whom intramedullary nailing has failed. Even if it means another surgical revision - is it possible to finally achieve consolidation with this method? Materials and methods: In this single-center, retrospective study all documents of patients who underwent tibiotalar and subtalar joints fusion using the Ilizarov external fixator at our institution from 2003 to 2023 as secondary treatment after frustrated first arthrodesis using an intramedullary nail were reviewed. Nineteen patients (17 men and 2 women), with an average age of 55.7 (standard deviation (SD) 8.7, range 34–75) years were included. Results: On average, 1.7 (SD 1.3, range 1–6) arthrodesis attempt were performed before final Ilizarov fixator arthrodesis. The average time spent in the Ilizarov fixator was 19 (SD 4, range 14–29) weeks. In seven cases (36.8%), both the tibiotalar and subtalar joints received bony consolidation in the end. Conclusion: If patients have undergone fusion of the tibiotalar and subtalar joints with a retrograde nail and this fails, it is difficult to achieve complete consolidation in the further course. A further attempt at arthrodesis using an Ilizarov fixator is possible, but the overall results are also poor. This procedure must therefore be seen as a last resort before amputation.


  • Open Access

    Analysis of compartment syndromes in lower extremity pediatric and adolescent trauma - are there predictors of a late onset?

    by Alexis Brinkemper, Silvia Jasmin Hufnagel, Jana Cibura, Dina Maria Sträter, Charlotte Cibura, Thomas Armin Schildhauer, Christiane Kruppa


  • Feasibility, safety, and functional outcomes using the neurological controlled Hybrid Assistive Limb exoskeleton (HAL®) following acute incomplete and complete spinal cord injury – Results of 50 patients

    by Mirko Aach, Thomas Armin Schildhauer, Amrei Zieriacks, Oliver Jansen, Martin Weßling, Alexis Brinkemper, Dennis Grasmücke

    Recent studies reveal that Hybrid Assistive Limb (HAL®) locomotion training in paraplegic patients suffering from chronic spinal cord injury (SCI) induces improvements in functional and ambulatory ...


  • Open Access

    HAL Training in Spinal Cord Injured Patients: A Narrative Review of 10 Years Experience

    by Alexis Brinkemper, Dennis Grasmücke, Emre Yilmaz, Thomas Armin Schildhauer, Mirko Aach

    To provide a summary and overview of the use of Hybrid Assistive Limb in spinal cord injured patients over the past 10 years. A review of the literature was performed via Web of Science and PubMed using the search terms “Hybrid assistive limb” or “HAL“ or “wearable robot“ or “exoskeleton” and “SCI” or “spinal cord injury” by two of the authors. Relevant articles were then studied in full text. Our review of the literature found 21 articles that met the inclusion criteria of this narrative review including 344 participants. Articles were sorted into two general categories: (1) clinical trials, and (2) single-case or two-case reports. The vast majority of patients improved functionally, showing increased walking distances, walking speeds, and endurance. In addition, a variety of other advances were described, such as temporary decrease in spasticity, improvement in bladder and bowel management, pain reduction, and change in muscle activity. Even though there is no uniform application of HAL training in people living with SCI the current study situation suggests that many patients could benefit from this innovative training within their means.


  • Open Access

    Rehabilitation of Acute Vs. Chronic Patients With Spinal Cord Injury With a Neurologically Controlled Hybrid Assistive Limb Exoskeleton: Is There a Difference in Outcome?

    by Amrei Zieriacks, Mirko Aach, Alexis Brinkemper, Daniela Koller, Thomas Armin Schildhauer, Dennis Grasmücke

    This study aimed to assess the outcome of acute and chronic participants with spinal cord injury (SCI) after 12 weeks of bodyweight supported treadmill training (BWSTT) with a hybrid assistive limb exoskeleton (HAL). Acute participants were defined as ≤12 months between SCI and training, chronic participants >12 months between SCI and training. We assessed whether HAL-assisted BWSTT is advantageous for acute and chronic participants and if length of time post injury impacts the outcome of HAL-assisted BWSTT. As the primary outcome, we assessed the time needed for the 10 meter walk test (10MWT). Hundred and twenty-one individuals participated in a 12-week HAL-assisted BWSTT five times a week. We regularly conducted a 10MWT, a 6 minute walk test (6MWT), and assessed the walking index for spinal cord injury (WISCI II) and lower extremity motor score (LEMS) to evaluate the gait performance without the exoskeleton. Distance and time were recorded by the treadmill while the participant was walking with the exoskeleton. All participants benefit from the 12-week HAL-assisted BWSTT. A significant difference between acute and chronic participants' outcomes was found in 6MWT, LEMS, and WISCI II, though not in 10MWT. Although chronic participants improved significantly lesser than acute participants, they did improve their outcome significantly compared to the beginning. Hybrid assistive limb-assisted BWSTT in the rehabilitation of patients with SCI is advantageous for both acute and chronic patients. We could not define a time related cut-off threshold following SCI for effectiveness of HAL-assisted BWSTT.